Y. Maeda

发表

Correlation between plasma concentration ratios of SN-38 glucuronide and SN-38 and neutropenia induction in patients with colorectal cancer and wild-type UGT1A1 gene.

T. Murakami, J. Hasegawa, K. Hirose, 2012, Oncology letters.

Correlation between plasma concentration ratios of SN-38 glucuronide and SN-38 and neutropenia induction in patients with colorectal cancer and wild-type UGT 1 A 1 gene

T. Murakami, J. Hasegawa, K. Hirose, 2022 .

Reduction in the rate of postoperative delirium by switching from famotidine to omeprazole in Japanese hepatectomized recipients

T. Murakami, Y. Maeda, M. Yamasaki, 2019, Journal of Pharmaceutical Health Care and Sciences.

Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015)　- Digest Version.

N. Hagiwara, W. Shimizu, T. Ikeda, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Evaluation of clinical efficacy of Maeda's nomogram for vancomycin dosage adjustment in adult Japanese MRSA pneumonia patients.

T. Murakami, K. Omoda, Y. Maeda, 2006, Drug metabolism and pharmacokinetics.

Dosage Adjustment of Dabigatran Etexilate Based on Creatinine Clearance in Patients With Cardioembolic Stroke or Atrial Fibrillation

T. Murakami, Y. Maeda, Mamoru Nakamura, 2016, Therapeutic drug monitoring.

Usefulness of one-point plasma SN-38G/SN-38 concentration ratios as a substitute for UGT1A1 genetic information after irinotecan administration

H. Takada, J. Hasegawa, Eiji Maruo, 2014, International Journal of Clinical Oncology.

Risk Factors for Cisplatin-Induced Anaphylactic Reactions in Transcatheter Arterial Infusion or Transcatheter Arterial Chemo-Embolization Chemotherapy

Sachiyo Funakoshi, Y. Maeda, T. Moriya, 2016 .

Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.

M. Okajima, Y. Masaoka, Y. Maeda, 1991, Scandinavian journal of gastroenterology.

Pharmaceutical Care with Pilsicainide Based on Renal Function Tests and Electrocardiograms

Yoshihisa Watanabe, Sachiyo Funakoshi, Yoshie Kiribayashi, 2007 .

Dosage Adjustment of Ribavirin Based on Renal Function in Japanese Patients with Chronic Hepatitis C

T. Murakami, M. Takano, Sachiyo Funakoshi, 2004, Therapeutic drug monitoring.

Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.

T. Konishi, M. Okajima, Y. Masaoka, 1993, Gut.

Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.

Y. Maeda, M. Takahashi, 1989, Journal of pharmacobio-dynamics.

Comparison of In Vitro Dissolution Profiles of Vancomycin and Cement Mechanical Strength among Vancomycin-laden Bone Cements Containing Various Commercial Vancomycin Products

M. Onda, F. Teraoka, Y. Arakawa, 2009 .

Effects of aluminium-containing antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester of ofloxacin as prodrug.

S. Hibino, S. Tsukiai, T. Konishi, 1993, Biological & pharmaceutical bulletin.

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

T. Murakami, Y. Maeda, 2023, Antibiotics.

Ester prodrugs of levofloxacin to prevent chelate formation in presence of aluminium ion

T. Murakami, Saki Otani, Y. Maeda, 2022, Pharmaceutical Sciences.

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

T. Murakami, Sachiyo Funakoshi, Y. Maeda, 2014, European Journal of Clinical Pharmacology.

Prescription Optimization through Pharmacokinetic Analyses of Patients with Side Effects

Y. Maeda, 2014 .

Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.

T. Murakami, R. Yumoto, M. Takano, 2005, Journal of pharmaceutical sciences.

Possible mechanism for pharmacokinetic interaction between lidocaine and mexiletine

T. Murakami, M. Takano, S. Tsukiai, 2002, Clinical pharmacology and therapeutics.

The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.

Y. Maeda, H. Tashiro, M. Takahashi, 1989, Journal of pharmacobio-dynamics.

A new simple test for evaluation of intestinal bacteria

Makoto Takahashi, T. Eto, Y. Maeda, 1990, World Journal of Surgery.

Study on the method to avoid infusion-site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

T. Murakami, K. Oda, N. Mori, 2022, Oncology letters.

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant

T. Murakami, K. Oda, Y. Maeda, 2019, Molecular and clinical oncology.

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

T. Murakami, Ami Okada, Y. Maeda, 2023, Pharmaceutics.

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

T. Murakami, Sachiyo Funakoshi, Y. Maeda, 2014, European Journal of Clinical Pharmacology.

Reduction in the rate of postoperative delirium by switching from famotidine to omeprazole in Japanese hepatectomized recipients

T. Murakami, Y. Maeda, M. Yamasaki, 2019, Journal of pharmaceutical health care and sciences.

The Assessment of Tobacco Smoke Exposure Based on the Presence of Metabolites of Nicotine in the Urine and its Clinical Application.

S. Tsukiai, T. Konishi, Sachiyo Funakoshi, 1997 .

Prevention of irinotecan-induced diarrhoea by oral carbonaceous adsorbent (Kremezin) in cancer patients.

T. Murakami, Yoshie Kiribayashi, Y. Maeda, 2004, Oncology reports.